Suppr超能文献

Determination of growth fractions in benign breast disease (BBD) with monoclonal antibody Ki-67.

作者信息

Lellé R J, Heidenreich W, Stauch G, Wecke I, Gerdes J

出版信息

J Cancer Res Clin Oncol. 1987;113(1):73-7. doi: 10.1007/BF00389970.

Abstract

Certain types of benign breast disease (BBD) carry an increased risk of malignancy. Several morphological criteria such as an atypia score are used to define this group, and the use of a kinetic parameter may provide additional information. Therefore, the growth fractions of 120 benign breast lesions were determined using the monoclonal antibody Ki-67. The values obtained range from 0.3% to 10.8% (average 3.1% +/- 2.2%) compared to breast carcinomas with an average of 15.3% +/- 10.1%, range 0.8% to 47.8%. All specimens were classified using the terminology of Azzopardi. The prevailing histological entities were cystic disease, fibroadenoma, and blunt duct adenosis. Between these groups no differences in growth fractions were observed. Postmenopausal patients had slightly lower values than premenopausal women. Further prospective studies are needed to evaluate whether those cases of BBD with a high number of Ki-67 positive cells have an increased risk of breast cancer, independently from conventional histological classifications.

摘要

相似文献

1
Determination of growth fractions in benign breast disease (BBD) with monoclonal antibody Ki-67.
J Cancer Res Clin Oncol. 1987;113(1):73-7. doi: 10.1007/BF00389970.
2
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
3
Systemic treatments for metastatic cutaneous melanoma.
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
4
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
8
Long-term hormone therapy for perimenopausal and postmenopausal women.
Cochrane Database Syst Rev. 2017 Jan 17;1(1):CD004143. doi: 10.1002/14651858.CD004143.pub5.
9
Benign Breast Disease and Breast Cancer Risk in the Percutaneous Biopsy Era.
JAMA Surg. 2024 Feb 1;159(2):193-201. doi: 10.1001/jamasurg.2023.6382.
10
Polyclonal and monoclonal antibodies for treating acute rejection episodes in kidney transplant recipients.
Cochrane Database Syst Rev. 2017 Jul 20;7(7):CD004756. doi: 10.1002/14651858.CD004756.pub4.

本文引用的文献

3
The epidemiology of benign breast disease.
Epidemiol Rev. 1981;3:184-202. doi: 10.1093/oxfordjournals.epirev.a036233.
4
Cell proliferation in fibrocystic disease and postmenopause breast ducts measured by thymidine labeling.
Cancer. 1982 Aug 15;50(4):746-51. doi: 10.1002/1097-0142(19820815)50:4<746::aid-cncr2820500420>3.0.co;2-a.
6
Is fibrocystic breast disease a pre-malignant state?
Acta Obstet Gynecol Scand Suppl. 1984;123:189-91. doi: 10.3109/00016348409157009.
7
Correlation of cell-cycle kinetics, hormone receptors, histopathology, and nodal status in human breast cancer.
Cancer. 1984 Oct 15;54(8):1586-90. doi: 10.1002/1097-0142(19841015)54:8<1586::aid-cncr2820540820>3.0.co;2-9.
10
Association of atypical characteristics of benign breast lesions with subsequent risk of breast cancer.
Cancer. 1972 Feb;29(2):338-43. doi: 10.1002/1097-0142(197202)29:2<338::aid-cncr2820290212>3.0.co;2-u.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验